Toda Pharma
Toda Pharma is a French company specialized in in vitro diagnostics, offering a wide range of rapid diagnostic products for professionals. Certified ISO13485, the company focuses on quality, innovation, and simplicity of use, providing solutions in obstetric diagnostics, tropical diseases, infectious diseases, urinary tests, and drug and alcohol testing. They are committed to quality, reliability, and technological advancement, with a strong international presence and participation in major health events.
Industries
Nr. of Employees
small (1-50)
Toda Pharma
2 rue du Rhin Napoléon, 67000 Strasbourg, France
Products
Nasal self-administered antigen test (home-use)
Nasal self-test antigen assay for home use with rapid results and usability features for lay users, including pediatric considerations.
Professional respiratory antigen test (nasal/oral)
Rapid antigen test intended for professional use with reported sensitivity/specificity and listings on validated test registries.
Multiplex respiratory antigen test (SARS-CoV-2 + Influenza A/B)
Rapid multiplex antigen assay for simultaneous detection of SARS-CoV-2 and influenza A/B antigens from a single swab specimen to aid differential diagnosis.
Saliva-based antigen screening tests
Rapid saliva antigen assays for SARS-CoV-2 with short time-to-result suitable for point-of-care or screening contexts.
Rapid serological antibody tests
Rapid serology tests for detection of antibodies to viral proteins in blood samples with short time-to-result.
Malaria rapid diagnostic tests
Rapid tests for detection and differentiation of malaria species in single-test and multi-test kit formats suitable for field use.
Nasal self-administered antigen test (home-use)
Nasal self-test antigen assay for home use with rapid results and usability features for lay users, including pediatric considerations.
Professional respiratory antigen test (nasal/oral)
Rapid antigen test intended for professional use with reported sensitivity/specificity and listings on validated test registries.
Multiplex respiratory antigen test (SARS-CoV-2 + Influenza A/B)
Rapid multiplex antigen assay for simultaneous detection of SARS-CoV-2 and influenza A/B antigens from a single swab specimen to aid differential diagnosis.
Saliva-based antigen screening tests
Rapid saliva antigen assays for SARS-CoV-2 with short time-to-result suitable for point-of-care or screening contexts.
Rapid serological antibody tests
Rapid serology tests for detection of antibodies to viral proteins in blood samples with short time-to-result.
Malaria rapid diagnostic tests
Rapid tests for detection and differentiation of malaria species in single-test and multi-test kit formats suitable for field use.
Services
Manufacture and supply of rapid IVDs in multiple formats for healthcare professionals and distributors, operated under an ISO 13485 quality management system with batch-level quality control.
Support for registration and listing of diagnostic devices on national competent authority lists and public portals, including documentation of analytical performance.
Custom quotations, order processing and commercial support for institutional and professional customers.
Manufacture and supply of rapid IVDs in multiple formats for healthcare professionals and distributors, operated under an ISO 13485 quality management system with batch-level quality control.
Support for registration and listing of diagnostic devices on national competent authority lists and public portals, including documentation of analytical performance.
Custom quotations, order processing and commercial support for institutional and professional customers.
Expertise Areas
- Rapid point-of-care in vitro diagnostics
- Lateral-flow antigen and serology testing
- Multiplex respiratory pathogen testing
- Drug and alcohol point-of-collection screening
Key Technologies
- Lateral-flow immunoassays
- Multiplex lateral-flow antigen assays
- Rapid serological immunoassays
- Saliva-based antigen assays
News & Updates
Participation at Arab Health 2023, one of the largest health fairs in the Middle East.
Participation in the Hospitalar fair in Sao Paulo, promoting French healthcare innovations.
Toda Pharma increases production of COVID-19 self-tests to meet rising demand.
Launch of Toda Fluronadiag, a multiplex test for flu and COVID-19 detection.
Participation at Arab Health 2023, showcasing latest rapid diagnostic innovations.
Participation in Sao Paulo's Hospitalar fair, promoting French healthcare quality.
Participation at Arab Health 2023, one of the largest health fairs in the Middle East.
Participation in the Hospitalar fair in Sao Paulo, promoting French healthcare innovations.
Toda Pharma increases production of COVID-19 self-tests to meet rising demand.
Launch of Toda Fluronadiag, a multiplex test for flu and COVID-19 detection.
Participation at Arab Health 2023, showcasing latest rapid diagnostic innovations.
Participation in Sao Paulo's Hospitalar fair, promoting French healthcare quality.